Introduction
The technology used to estimate intraocular pressure (IOP) has evolved tremendously since Sir William Bowman emphasized the importance of ocular tension measurements. In an address delivered at the 1826 meeting of the British Medical Association, Sir William underscored the critical role that digital estimation of ocular tension played in his practice. (In this case the term "digital" refers to palpation of the eyes using the fingers-the digits.) In his address, Sir William stated: "…it is now my constant practice, where defective vision is complained of, to ascertain almost at the first instant the state of tension in the eye.… It is easy enough to estimate the tension of the eye, though there is a right and a wrong way of doing even so simple a thing…. With medical men, the touch is already an educated sense, and a very little practice should suffice to apply it successfully to the eye." (Bowman, 1856) Soon afterwards, digital palpation tonometry became an essential clinical skill to be mastered by all ophthalmologists. When mechanical tonometry was first introduced in the late 1800s, many ophthalmologists felt so confident with their ability to estimate IOP by palpation that they viewed the new technology as inferior. We have indeed come a long way from there and there is currently no doubt on the need to perform tonometry as an essential measurement performed in any ocular examination. IOP has been associated with glaucoma for a long time and clinicians managing glaucoma patients have a love hate relationship with IOP. This is in part due to errors in tonometry and the variability in measurement of IOP. As clinicians we look for data that is helpful in managing a disease, data that is consistent, reproducible and accurate. IOP, like many other physiological measurements, is in a state of flux and can vary both short term and long term. To complicate the issues further, there are numerous ocular biomechanical factors like central corneal thickness, corneal curvature, corneal rigidity and hydration that can lead to errors in IOP measurement clinically . (Brandt et al, 2001; Goldmann & Schmidt, 1957; Liu & Roberts, 2005; Orssengo & Pye, 1999; Whitacre et al, 1993) Contrary to once believed, high IOP value is not as integral to the diagnosis of glaucoma and one-off IOP measurement of 21 mmHg or greater does not constitute a diagnosis of glaucoma. While ocular hypertensive patients have IOP that is consistently over 21 mmHg, a pressure below this value does not equate to physiological normality. Despite these arguments, IOP remains the single most important alterable risk factor in the management of glaucoma as has been pointed out by various epidemiological studies (Goldmann & Schmidt, 1957; Schnabel, 1908) . However, there are numerous factors that may lead to frank errors in IOP measurement (Whitacre and Stein 1993) and others that lead to IOP fluctuation. Overall IOP is thought to show polygenic inheritance with a definite environmental contribution. (Goldmann, 1961) The factors that can contribute to long term fluctuations or variations in IOP are age, blood pressure and seasonal variations (Whitacre and Stein 1993) . While these factors are of theoretical interest, they are of minimal clinical importance and tend to co-vary. The factors that contribute to short term fluctuations in IOP are diurnal variations, body posture, exercise, eye movements, activities causing valsalva maneuver and food and drug effects. (Bowman, 1852) These factors can pose a significant problem in clinical management, as level of IOP is one of the integral measurements that help decide the clinical efficacy of glaucoma medications and to some extent the management strategy in patients with or at risk of glaucoma. These short term fluctuations in IOP make the case for having many IOP measurements at different times of day and possibly continuous IOP monitoring diurnally to initiating therapy or making changes to the management of patients. This chapter will address the following areas: 1) past and present technologies available to perform IOP measurement through tonometry 2) the principles behind tonometry devices 3)The errors in IOP measurement caused by physiological variations in ocular parameters, when measurements are made by the Goldmann applanation tonometer 4) tonometric correction factors that have been developed for the Goldmann applanation tonometer to eliminate errors in IOP measurement when mea, and 4) the continuous monitoring of IOP using telemetry methods.
Historical perspectives

Impression tonometry
Although Albrecht von Graefe is credited with the first attempts to create instruments that mechanically measured IOP in the early 1860s, his proposed instruments were neither designed nor built. Rather, it was Donders who designed the first instrument capable of estimating IOP -albeit not accurately -in the mid 1860s. With this instrument, which was refined by Smith and Lazerat in the 1880s, ophthalmologists first measured the curvature of the sclera at the site of contact and used the measurement to determine the depth of indentation produced by the tonometer tip. However, the later discovery of cocaine by Carl Koller in 1884 led the way to corneal impression tonometry. Using corneal anesthesia, corneal tonometry became the definitive choice for IOP measurement because it offered a well-defined and uniform site of impression. The major shortcoming of impression tonometry was that it displaced so much fluid upon contact with the eye that the measured readings were highly variable and mostly inaccurate. What was needed was a way to displace a minimal amount of fluid to record IOP. This breakthrough came in 1867 when Adolf Weber designed the first applanation tonometer that gave a highly defined applanation point without indentation. After two decades of skepticism, the value of applanation tonometry was re-discovered when Alexei Maklakoff and others introduced new versions of applanation tonometers similar to that depicted in figure 1. In the early 20th century, while many tonometer models had become available, digital palpation tonometry remained the "gold standard" among most ophthalmologists. (Kniestedt et al, 2004) The first commonly used mechanical tonometer was designed and introduced by Hjalmar Schiotz in the early 1900s (figure 2). The instrument was simple, easy to use and relatively precise. It was quickly accepted and became the new gold standard beginning the 1910s. Innovations in calibration led to its increased use, and a tremendous amount of knowledge about the normal and glaucomatous eye was quickly acquired. 
Indentation (Schiotz) tonometry
This type of tonometry uses a plunger to indent the cornea. IOP is determined by measuring how much the cornea is indented by a given weight. The test is less accurate than applanation tonometry and is not commonly used today by ophthalmologists and optometrists.
Goldmann Applanation Tonometer
Since its introduction in the 1950s, the Goldmann Applanation Tonometer (GAT) has gained widespread acceptance and remained the reference standard in tonometry (ISO, 2001 ). The technique is based on Imbert-Fick law, according to which the intraocular pressure (IOP), p, is inferred from the force, W, required to applanate a certain area, A, of the central cornea, 
Where s and b represent the surface tension force caused by the tear film, and the bending resistance of the cornea, respectively. With this equation in mind, it was found that with an applanation diameter of 3.06mm, and hence an applanation area, A = 7.35mm 2 , the effects of surface tension and bending resistance become equal and cancel each other out (Ehlers et al, 1975; Goldmann, & Schmidt, 1957; Whitacre et all, 1993) reducing Equation 2 to the simpler form of Equation 1. The tonometer uses a special disinfected truncated cone mounted on the tonometer's head and positioned against the cornea. The force causing the cone to applanate the central cornea is increased gradually until the required area of applanation is achieved. At this point, the applanation pressure, which can be read from the pressure application mechanism, is recorded and considered equal to the IOP. Perkins, a portable version of GAT, has been developed to enable measurement of IOP in patients who are unable to undergo the sitting slit-lamp examination required with GAT. In both GAT and Perkins, and due to the contact nature of the procedure, a topical anaesthetic is applied onto the surface of the cornea in the form of eye drops. 
McKay-Marg and TonoPen tonometry
In 1959, McKay and Marg introduced their tonometer based on a combination of indentation and applanation processes. The tonometer has a 3.06-mm diameter applanating surface which is obtained by the footplate. Protruding by a microscopic amount from the center is a tiny plunger attached to a strain gauge. As the tonometer is brought in contact with the eye, the plunger gets resistance from the cornea and IOP producing a rising record of the force by the strain gauge. At the moment of applanation, the force is shared by the foot plate and the plunger so that there is a momentary, small decrease from the steadily increasing force. This phenomenon is used in the tonometer to determine the point of applanation, and the small notch observed in the electrical waveform helps identify the force at applanation. Because the area of applanation is known, ( figure 5A ) the IOP can be calculated. As the device is pushed further into the cornea, the cornea is deformed slightly, and the aqueous fluid is displaced so that the IOP actually rises from resting state to a somewhat higher state. Although this amount of displacement of fluid and the associated increase in IOP are more than is seen with pure applanation devices, they are not enough to cause major errors in the readings. The McKay-Marg tonometer correlates well with other applanation tonometers. (Augsburger & Terry, 1977) It is, perhaps, less dependent on corneal factors than Goldmann tonometry but less reliable than newer methods such as ORA or DCT. The McKay-Marg tonometer performs well in corneas whose surface is irregular or scarred; here, the McKayMarg is more accurate than Goldmann-type tonometers, in part, because the endpoint is mechanical not optical. (Kaufman et al, 1970; McMillan & Forster, 1975) The McKay-Marg tonometer is not in production any more, but its engineering offspring, the Tonopen (Reichert Ophthalmics, Buffalo, NY) incorporate the same principles in a small, handheld, battery-powered body with internal chips that can read the "notch" electronically and average multiple readings. In large groups, the readings of a Oculab Tono-pen correlate well with Goldmann measurements, but significant variations may occur from Goldmann readings in some patients. (Frenkel et al, 1988; Kao et al. 1991) The Tono-Pen (or its newer model cousins, the Tono-Pen XL(figure 5 B) and Tono-Pen Avia; Reichert ( Figure 6 )) has the advantage of being portable, usable in both the upright and supine positions and not dependent on a source of alternating current. (Hessemer, 1988) Hence, it may be very useful in screening situations especially where a source of electricity is lacking. It is also useful at the bedside or in the operating room. The Tono-Pen is able to record IOP through a bandage contact lens, which makes it useful in eyes with alkali or other chemical burns, chronic neurotrophic ulceration, and other situations where a bandage contact lens is therapeutically indicated and where removing it for pressure measurement may cause problems. (Mark et al, 1992; Panek et al, 1990) Fig. 5.
The Tono-Pen is used with disposable latex covers with a new one used for each patient reducing the chance of transmission of infectious agents. However, this adds to the cost of pressure measurement, as does the need for battery replacement. As noted above, there may
Tonometry -Past, Present and Future 91 be significant variation from Goldmann readings. It is not known if this is because of inaccuracy on the part of the Tono-Pen or the Goldmann. The Tono-Pen gives a similar snapshot of IOP as the airpuff type tonometers. From the Tono-Pen readings, it is difficult to ascertain the size of the IOP pulse or where in that pulse wave the pressure reading may be. The Tono-Pen XL takes an average of 4 readings and the Tono-Pen Avia 10 readings, and each gives a statistical indicator of reliability.
Fig. 6. Tono-Pen Avia
Non-Contact Tonometry (NCT)
In 1970's individuals without a medical degree were not permitted to instill topical anesthesia which was a pre-requisite to perform tonometry with any device. Non-contact tonometry was a timely invention of Dr. Bernard Grolman which allowed optometrists to measure IOP without the need of anesthesia (Reichert website 2011). Non-contact (also called air-puff) tonometers do not touch the eye because they use a puff of air to flatten (applanate) the cornea. Once initiated, the puff force increases until the cornea is applanated over a predetermined area. The tonometer then translates the applanation force into a measure of IOP (see figure 3 ). Because the air puff tonometer relies on corneal applanation, it is subject to the same potential measurement errors induced by variations in corneal properties, as is the Goldmann tonometer and these errors are exaggerated in the measurement outcome (Tonnu et al, 2005) An additional source of error in NCT measurements is that IOP is determined at a single very brief instant in time and IOP can pulsate considerably over time as the choroid fills with blood and then empties in concert with the cardiac cycle. This phenomenon can be directly observed by viewing pulsation of mires during Goldmann tonometry. (To some degree, Goldmann takes this pressure variation into account because measurements are made when the inner aspects of the pulsating mires just touch.) In some individuals, IOP can vary as much as 5 or 6 mm Hg within one second while the choroid fills and empties. The NCT has no ability to determine at what point in an individual's intraocular pressure cycle the IOP is measured. These issues are better handled by devices that continuously measure IOP for 8 seconds or longer (figure 4). 
Major errors in IOP measurements using the Goldmann Applanation Tonometer
The errors in tonometry mentioned below that affect the Goldmann applanation tonometer (GAT) also affect other tonomters that includes all Goldmann type tonometers, other contact tonometers like the Tonopen, rebound tonometry and also the conventional non-contact tonometers. The discussion of the errors specific to each tonometer is beyond the scope of this chapter and we will concentrate on the clinical gold standard the GAT. The status of GAT as the reference standard in tonometry has been maintained in spite of its inventors' acknowledgement in 1957 of sources of inaccuracy (Goldmann, 1957) , most notably the variation of central corneal thickness (CCT). Since then, numerous studies have been conducted to assess the effect of CCT variation on GAT and to develop correction nomograms that could be used in clinical practice to reduce this effect. The first such study was conducted by Ehlers et al (Ehlers, 1975) in 1975 who found GAT measurement of IOP (denoted IOPG) to differ by 7.1 mmHg for every 100 m change in CCT. This work was followed by several others, most of which agreed with Ehlers' notion of strong association between IOPG and CCT but derived lower slopes of association, widely ranging between 0.7 and 4.5 mmHg, Table 1 . (Brandt, 2001; Gimeno, 2000; Munger et al 1998; Orssengo & Pye, 1999; Shih et al, 2004; Whitacre, 1993; Wolfs et al, 1997) Subsequent studies (Liu & Roberts, 2005 , Kirstein & Huessler, 2005 suggested that it was corneal stiffness, or mechanical resistance to deformation under tonometry loading, rather than CCT alone that was responsible for errors in GAT. This observation drew attention to other factors that could affect corneal stiffness starting with central corneal curvature. (Liu & Roberts, 2005) However, the studies did not agree on the magnitude of the curvature effect on IOPG, and found the effect to remain below 1.14 mmHg per 1mm change in the central anterior radius, R, Table 2 . (Munger et al, 1998; Rehany et al, 2000) The effect of the material properties of corneal tissue on GAT was also considered and found to be significant (Hamilton & Pye, 2008; Liu & Roberts, 2005; Orssengo & Pye, 1999) , but the practical value of this finding is limited by the current inability to measure corneal material properties in vivo. Later research identified an age-related stiffening trend of corneal tissue (Elsheikh, 2007 (Elsheikh, , 2008 and was able to determine the subsequent effect on GAT (Elsheikh, 2010) . However, it is now known that corneal material properties are affected by other factors besides age, including swelling (Hamilton et al, 2007; Kotecha, 2009; Shah, 2000) , ectasia (Nash et al , 1982) , wound healing (Dupps & Wilson, 2006) and stromal cross-linking damage in keratoconus (Andreassen et al, 1980; Meek et al, 2005; Radner et al, 1998) . The effect of these factors on the material properties, and hence on GAT, is yet to be determined. Table 2 .
Correction factors
Correction factors of GAT IOP based on central corneal radius variations
Ehler's study, correction factors were provided in a tabulated form for specific values of IOPG and CCT (in mmHg and m, respectively). This information was later used to derive the following correction equation using the least squares method. 
In these equations, CCT is in m, R in mm, IOPT (estimate of true IOP) and IOPG in mmHg, and A( ) a theoretically drawn parameter that varied with CCT and R.
Other studies used mathematical analysis of the applanation process to produce IOPG correction equations, the most significant of which is that derived by Orssengo and Pye in 1999 : (Orssengo & Pye, 1999) www.intechopen.com (Bryant et al, 1996; Vito et al, 1989) . A more recent numerical study produced the only correction equation that considered the combined effects of CCT, R, age and the IOPG level (Elsheikh et al, 2010) . This equation was successfully validated both experimentally and clinically and found to reduce the association of IOPG with all stiffness parameters considered. 3.2 Can we do better than the 50 year old "Gold Standard?" As discussed in the previous section, the equation derived by Elsheikh and coworkers helps decrease the overall effect of CCT, R and age on IOP measurements. However it has to be remembered that when correcting IOP of an individual, residual errors may still persist and these may be significant. It would be ideal if tonometers provided measurements that were independent of ocular parameters. The "new age" tonometers like the Pascal Dynamic Contour Tonometer (Ziemer Ophthalmic Systems) and the Ocular Response Analyzer (Reichert technologies, Inc) have been to provide IOP that are relatively independent of biomechanical properties related to central corneal thickness and curvature (Kaufmann et al, 2004; Madeiros & Weinreb, 2006) . Studies have claimed superiority for these devices compared to conventional tonometry in various pathologies like keratoconus (Gkika et al, 2011) and post LASIK (laser insitu keratomileusis) (Kaufman et al, 2003; Kirwan & O'Keefe, 2008) . In a study performed in vivo, Andreas Boehm compared IOP in the anterior chamber with Pascal measurements prior to cataract surgery. (Boehm et al, 2008) This study demonstrated that DCT values were reliably within one millimeter of actual manometric IOP. In a more recent comparison between GAT and DCT IOP, Kotecha et al showed that DCT was more precise and reliable than GAT. (Kotecha et al, 2010) 
The PASCAL® -Dynamic Contour Tonometer (DCT)
Dynamic contour tonometry (DCT) (figures 10,11 ) is a novel measuring technique using the principle of contour matching instead of applanation to eliminate the systematic errors inherent in previous tonometers. These factors include the influence of corneal thickness, rigidity, curvature, and elastic properties. The net effect of the increased precision that the DCT delivers would be a reduction in false positives and, more importantly, false negatives in IOP measurement. With more precise IOP measurement, researchers and clinicians could develop a more meaningful understanding of the role of IOP in the pathogenesis and management of glaucoma. The PASCAL® (DCT) tonometer (Ziemer Ophthalmic Systems, AG, Switzerland) was designed with the goal of minimizing the unwanted effects of variability of corneal s t r u c t u r a l d y n a m i c s o n t h e m e a s u r e m e n t o f I O P . A l t h o u g h t h i s d e v i c e i s s i m i l a r i n appearance to a Goldmann, it is unlike Goldmann applanation in that it is not a variable force tonometer and uses a miniature piezoresistive pressure sensor embedded within a tonometer tip contour-matched to the shape of the cornea. The tonometer tip rests on the cornea with a constant appositional force of one gram. This is an important difference from all forms of applanation tonometry in which the probe force is variable. When the sensor is subjected to a change in pressure, the electrical resistance is altered and the DCT's computer calculates a change in pressure in concordance with the change in resistance. The contour matched tip has a concave surface of radius 10.5 mm, which approximates the cornea's shape when the pressures on both sides of it are equal. This is the key to the DCT ability to neutralize the effect of intra-individual variation in corneal properties. (Kaufman et al, 2003; Kniestadt, 2004; Mueller-Holz et al, 2006) Fig. 9. Juxtaposition of cornea and PASCAL tip
Once a portion of the central cornea has taken up the shape of the tip (figure 9), the integrated pressure sensor begins to acquire data, measuring IOP 100 times per second. A complete measurement cycle requires about 8 seconds of contact time. During the 98 measurement cycle, audio feedback is generated, which helps the clinician insure proper contact with the cornea. 
Ocular Response Analyzer
Unlike the prior generations of non-contact tonometers which were based on the original design developed in 1970s, the Ocular Response Analyzer is a non-contact tonometer that provides IOP values that are independent of corneal properties (Luce, 2005; Madeiros & Weinreb, 2006) . Additionally the ocular response analyzer provides parameters that are indicative of the biomechanical properties of the cornea 97 . Using a jet of air, most prior generation non-contact tonometers applanate the cornea in 1-3 milliseconds. The ocular response analyzer uses a slightly longer pulse of approximately 10 milliseconds. The longer pulse gives the ocular response analyzer added information that is not available to the traditional non-contact tonometers. Once applanation is reached (which also is the signal for the air-jet to shut down) there is a slight delay in the signal to shut down which causes the cornea to indent or become concave. Subsequent to concavity of cornea and prior to reaching its original position, cornea reaches applanated state for the second time. The instrument records both onward applanation and backward applanation; the difference between the two values is Corneal Hysteresis which is a direct measure of corneal biomechanical properties (Luce, 2005) Corneal hysteresis is defined as the difference between inward and outward applanation pressures. In this chart, a measurement of corneal hysteresis is illustrated on a curve, which compares corneal applanation signal and air pressure over time.
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6. Tonometers with research and clinical utility 6.1 Rebound tonometry One of the newest tonometers is the rebound tonometer ( figure 13 ). This device arose from the need for a tonometer that was accurate in small animals such as mice without having to place them under general anesthesia or heavy sedation. Their eyes are so small that applanation tonometers are too big for accurate readings. The rebound tonometer was found to be quite accurate in these animals despite constant movement (Danias et al, 2003; Goldblum et al, 2002 : Kontiola, 1996 The rebound tonometer (RBT) is an assembly of two coils coaxial to a probe shaft that bounce a magnetized probe off the cornea and detect the deceleration of the probe caused by the eye. A moving magnet within a coil induces changes in the voltage at the two ends of the coil generating a magnetic field with a given voltage, which is detected by the tonometer sensor. The voltage produced is proportional to the probe speed. Of all the variables linked to the probe's movement, the inverse of its deceleration speed seems to correlate best with IOP. (Kontiola, 1996) The probes used by the tonometer are disposable and are 24 mm long and weigh 11 mg. The probe tip has a 1-mm-diameter plastic cover, to minimize corneal damage.
Fig. 13. The Rebound Tonometer
The probe used to measure IOP is a tiny 1.8-mm diameter plastic ball on a stainless steel wire is held in place by an electromagnetic field in a handheld battery-powered unit (Fig.  13) . When the button on the back is pushed, a spring drives the wire and ball forward rapidly. When the probe hits the cornea, the ball and wire decelerate; the deceleration is more rapid if the IOP is high and slower if the IOP is low. The speed of deceleration is measured internally and a chip calculates the IOP. As noted above, this tonometer was developed for laboratory research in small animals. Its accuracy has been demonstrated in a number of studies in mice. Because the probe makes contact with the cornea for microseconds, no anesthetic is necessary in either animals or humans. (Kontiola & Puska, 2004) Perhaps because the rebound tonometer has the least contact time with the eye of any tonometer and so may get a reading at any point in the IOP pulse cycle, its repeatability suffers compared with Goldmann tonometry. (Dekking & Coster, 1967) www.intechopen.com
Tonometry -Past, Present and Future
101
The probes are disposable between patients, so, disinfection is not necessary. The disadvantages are that it can only be used in an upright patient (the probe falls out if the instrument is facing downward). Accuracy may be an issue especially in patients where accurate IOP measurements are critical for long-term management.
IOP Telemetry devices
At present, the only therapeutic approach in glaucoma is to lower IOP, whether or not IOP is above the normal range. Typically, when therapy is initiated, a target pressure is set, based on the IOP before treatment, the amount of glaucoma damage present and the lifeexpectancy of the patient. Therefore, an accurate assessment of the IOP both before and after initiating therapy is key. Current practice to monitor IOP is based on taking measurements during the few minutes at the clinic two or three times a year. These measurements are unlikely to characterise the IOP sufficiently well, as IOP varies considerably due to changes in posture and physiologic state, and during sleeping and awakening. Studies reported that there was only a 60-70% chance of capturing the peak IOP if the IOP was measured only during office hours (Kitazawa & Horie, 1975) . Others found that 2 to 4 hourly IOP monitoring over a 24-hour period (which requires hospitalisation) resulted in a change in the clinical management of glaucoma in more than 75% of patients (Hughes et al, 2003) . Further research on normal tension glaucoma, a type of glaucoma that develops in people with IOP measurements within the normal range, found that the progression of the disease was related to IOP fluctuations, which could not be identified by measurements made during a clinic visit (Hong et al, 2007) . Reports also concluded that current measurement methods were insufficient to monitor the circadian fluctuation in IOP (of up to 11mmHg) (Kitazawa & Horie, 1975 ) -possibly another glaucoma risk factor. These studies identified the need for devices that can effectively monitor IOP continuously over long periods of at least 24 hours (Brandt, 2007) . The concept of an IOP continuous measurement device is not new. Several recent efforts have resulted in at least ten patented systems. Many of these systems employ a pressure sensor to be surgically implanted inside the ocular globe or within the thickness of the cornea. For this reason, these systems have not been used except in cases where surgical intervention is required for another reason. Examples of this technology include the systems developed by (Abita et al, 2003; Lloyd et al, 2003; Jeffries et al, 2001 ; and sketched in Figure 14 .
Fig. 14. IOP measurement techniques involving surgically implanted pressure sensors: (a) An IOP sensor implanted within corneal thickness (Abita et al, 2003 ) (b) IOP monitoring system employing a vitreal chamber implant (Lloyd et al, 2003 ) (c) An IOP sensor attached surgically to the eye iris (Jeffries & Birchansky, 2001) Other systems employ non-invasive devices bearing against the sclera, so as to avoid affecting the user's vision. Examples include the systems developed by Kursar (1993) and Couvillon et al (1976) , see Figure 15 . These systems, which rely on indenting the stiff sclera, are bulky and uncomfortable to wear, and may affect corneal physiology, possibly leading to inaccuracies in IOP measurement. There have also been attempts to incorporate a pressure measurement device in a corneal contact lens. In 1990, Waters et al (Vanderploeg & Ginsburg, 2011 ) developed a contact lens that employed a pressure sensor requiring a flat back surface, Figure 16a . The flat surface of the lens is likely to change the refractive power of the eye and hence affect the patient's eyesight while wearing it. A more recently developed system is that by Fleischman et al (2007) which uses a contact lens with a built in pressure sensor, Figure 16b . The patient uses a plunger, which is pushed against the eyelid, which then activates the sensor manually. This method of operation made the system unsuitable for the continuous measurement of IOP and dependent on the patient's ability to activate it. The only system that is expected to appear on the market soon is the Triggerfish designed by Leonardi et al (2004) and developed by Sensimed, Switzerland, Figure 16c . The system incorporates a contact lens fitted with a circumferential strain gauge that detects IOP changes. A microprocessor embedded within the thickness of the contact lens controls the operation of the strain gauge and the communication of the IOP measurements to an external instrument through two magnetic coils; an exciter coil on a pair of glasses and a respondent coil on the contact lens. The device has been recently validated in a clinical study (Mansouri & Shaarawy, 2011) .
(a) (b) Fig. 15 . IOP monitoring systems employing sclera-mounted pressure sensors: (a) An IOP sensor in the form of a scleral indentor (Kursar, 2003) (b) A scleral applanator forming part of the IOP measurement device (Read et al, 2010) www.intechopen.com (Waters et al, 1990 ) (b) A corneamounted IOP sensor activated by a plunger (Fleischman et al, 2007 ) (c) A contact lens with IOP measurement sensor and an unobstructed visual zone (Leonardi et al, 2004) 
Conclusion
It is not an exaggeration to say that tonometry and intraocular pressure have had a long journey. Despite the shortcomings and errors in measurement, IOP remains the most important risk factor of glaucoma. The extensive research into tonometry has yielded numerous technological advances and sophisticated "new age" tonometers the Ocular Response Analyzer and the Pascal dynamic contour tonometer. These devices are reported to be less erroneous than the "clinical gold standard" the Goldmann applanation tonometer. We hope that over time the new age tonometers will replace the current clinical gold standard. The rebound tonometer fast becoming the tonometer of choice in measuring IOP in animal experiments and may have a role to play in clinical screenings. IOP telemetry promises to fulfil the gaps in glaucoma management by providing the information on 24-hour diurnal variation in IOP. How this piece of information will change the face of glaucoma management remains to be determined.
